Pages that link to "Q40697369"
Jump to navigation
Jump to search
The following pages link to Translocation (3;21)(q26;q22) in therapy-related myelodysplasia following drugs targeting DNA-topoisomerase II combined with alkylating agents, and in myeloproliferative disorders undergoing spontaneous leukemic transformation (Q40697369):
Displaying 13 items.
- AML1 interconnected pathways of leukemogenesis (Q28184349) (← links)
- Therapy-related myeloid leukemia (Q28284888) (← links)
- Chromosomal abnormalities in acute leukemias. (Q33854456) (← links)
- Topoisomerase II inhibitor-related acute myeloid leukaemia (Q33940241) (← links)
- Abnormalities of 3q21 and 3q26 in myeloid malignancy: a United Kingdom Cancer Cytogenetic Group study (Q34369958) (← links)
- Secondary myelodysplastic syndrome after fludarabine therapy of a low-grade non-Hodgkin's lymphoma (Q39223633) (← links)
- Selection of a subpopulation with fewer DNA topoisomerase II alpha gene copies in a doxorubicin-resistant cell line panel (Q39998037) (← links)
- Spectral karyotyping (SKY) refinement of a complex karyotype with t(20;21) in a Ph-positive CML patient submitted to peripheral blood stem cell transplantation (Q52541721) (← links)
- Acute myeloid leukemia (Q58481761) (← links)
- Acute Myeloid Leukemia (Q58481811) (← links)
- A unique AML1 (CBF2A) rearrangement, t(1;21)(p32;q22), observed in a patient with acute myelomonocytic leukemia (Q74536317) (← links)
- Cytogenetically unrelated clones in therapy-related myelodysplasia and acute myeloid leukemia: experience from the Copenhagen series updated to 180 consecutive cases (Q77585716) (← links)
- Myelodysplastic Syndrome/Acute Myeloid Leukemia With t(3;21)(q26.2;q22) Is Commonly a Therapy-Related Disease Associated With Poor Outcome (Q84394931) (← links)